CHRM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: A recent study described an increase of autoantibodies against the β2 adrenergic receptor (β2 AdR) and M3 muscarinic receptor, both essential receptors in vasodilation in ME/CFS patients [34].